TOP

Research Article

Split Viewer

Mol. Cells 2003; 16(3): 385-391

Published online January 1, 1970

© The Korean Society for Molecular and Cellular Biology

Enhanced Uptake of a Heterologous Protein with an HIV-1 Tat Protein Transduction Domains (PTD) at Both Termini

Jiyoon Ryu, Kyuhyung Han, Jinseu Park, Soo Young Choi

Abstract

Poor membrane permeability of proteins is a major limitation of protein therapy. In a previous study, we showed that the minimal sequence required for effi-cient transduction of Tat-GFP is the basic domain from 49-57 of HIV-1 Tat called the protein transduc-tion domain (PTD. Here we have generated HIV-1 Tat PTD GFP fusion proteins in which HIV-1 Tat PTD is fused with the N- and/or C-termini of GFP. The vari-ous GFP fusion proteins were purified from Es-cherichia coli and characterized for their ability to enter mammalian cells using Western blot analysis, confocal microscopy and flow cytometry. The GFP fusion protein with Tat PTD at its C-terminus was taken up as efficiently as the GFP fusion protein with Tat PTD at its N-terminus. However, the same protein with PTDs at its both termini was taken up even more efficiently. All the GFP fusion proteins were present in both the nucleus and cytosol of the transduced cells. Uptake was lower at 4

Keywords HIV-1-Tat; Protein Therapy; Protein Transduction; Tat-GFP-Tat; Transduction Efficiency

Article

Research Article

Mol. Cells 2003; 16(3): 385-391

Published online December 31, 2003

Copyright © The Korean Society for Molecular and Cellular Biology.

Enhanced Uptake of a Heterologous Protein with an HIV-1 Tat Protein Transduction Domains (PTD) at Both Termini

Jiyoon Ryu, Kyuhyung Han, Jinseu Park, Soo Young Choi

Abstract

Poor membrane permeability of proteins is a major limitation of protein therapy. In a previous study, we showed that the minimal sequence required for effi-cient transduction of Tat-GFP is the basic domain from 49-57 of HIV-1 Tat called the protein transduc-tion domain (PTD. Here we have generated HIV-1 Tat PTD GFP fusion proteins in which HIV-1 Tat PTD is fused with the N- and/or C-termini of GFP. The vari-ous GFP fusion proteins were purified from Es-cherichia coli and characterized for their ability to enter mammalian cells using Western blot analysis, confocal microscopy and flow cytometry. The GFP fusion protein with Tat PTD at its C-terminus was taken up as efficiently as the GFP fusion protein with Tat PTD at its N-terminus. However, the same protein with PTDs at its both termini was taken up even more efficiently. All the GFP fusion proteins were present in both the nucleus and cytosol of the transduced cells. Uptake was lower at 4

Keywords: HIV-1-Tat, Protein Therapy, Protein Transduction, Tat-GFP-Tat, Transduction Efficiency

Mol. Cells
Sep 30, 2023 Vol.46 No.9, pp. 527~572
COVER PICTURE
Chronic obstructive pulmonary disease (COPD) is marked by airspace enlargement (emphysema) and small airway fibrosis, leading to airflow obstruction and eventual respiratory failure. Shown is a microphotograph of hematoxylin and eosin (H&E)-stained histological sections of the enlarged alveoli as an indicator of emphysema. Piao et al. (pp. 558-572) demonstrate that recombinant human hyaluronan and proteoglycan link protein 1 (rhHAPLN1) significantly reduces the extended airspaces of the emphysematous alveoli by increasing the levels of TGF-β receptor I and SIRT1/6, as a previously unrecognized mechanism in human alveolar epithelial cells, and consequently mitigates COPD.

Share this article on

  • line

Molecules and Cells

eISSN 0219-1032
qr-code Download